Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

LAVAL, Quebec -- Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has concluded the asset purchase agreement (the “Purchase Agreement”) to acquire all of the non-real estate business assets of Occy Laboratory Inc. (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”). The acquired assets include Occy’s manufacturing equipment, inventory, customer network and intellectual property (the “Assets”). Read More

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory